Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 17-23 , September 2006

Oligodendrocyte precursor cells express a functional chemokine receptor CCR3: Implications for myelination

  • Samaneh Maysami

      Affiliations

    • Department of Neurology, Medical School Hannover, Hannover, Germany
    • Center for Systems Neuroscience, Germany
    • These authors contributed equally.
    • ,
  • Dan Nguyen

      Affiliations

    • Department of Neurology, Infectious Diseases and Rheumatology, Campus Benjamin Franklin, Charité, Berlin, Germany
    • These authors contributed equally.
    • ,
  • Franziska Zobel

      Affiliations

    • Department of Neurology, Infectious Diseases and Rheumatology, Campus Benjamin Franklin, Charité, Berlin, Germany
    • ,
  • Sandra Heine

      Affiliations

    • Department of Neurology, Medical School Hannover, Hannover, Germany
    • ,
  • Michael Höpfner

      Affiliations

    • Medical Clinic I, Gastroenterology, Infectious Diseases and Rheumatology, Campus Benjamin Franklin, Charité, Berlin, Germany
    • ,
  • Martin Stangel

      Affiliations

    • Department of Neurology, Medical School Hannover, Hannover, Germany
    • Center for Systems Neuroscience, Germany
    • Corresponding Author InformationCorresponding author. Department of Neurology, Medical School Hannover, Carl-Neuberg-Strasse 1, 30623 Hannover, Germany. Te.: +49 511 532 6676; fax: +49 511 532 3115.

Received 12 March 2006 ,Revised 23 May 2006 ,Accepted 24 May 2006.

References 

  1. Ambrosini E, Aloisi F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem. Res. 2004;29:1017–1038
  2. Asakura K, Hunter SF, Rodriguez M. Effects of transforming growth factor-β on platelet-derived growth factor on oligodendrocyte precursors: insights gained from a neuronal cell line. J. Neurochem. 1997;68:2281–2290
  3. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565–568
  4. Bajetto A, Bonavia R, Barbero S, Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 2002;82:1311–1329
  5. Baranzini SE, Elfstrom C, Chang S-Y, Butunoi C, Murray R, Higuchi R, et al. Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression. J. Immunol. 2000;165:6576–6582
  6. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 2001;81:871–927
  7. Bozzali M, Wrabetz L. Axonal signals and oligodendrocyte differentiation. Neurochem. Res. 2004;29:979–988
  8. Dorf ME, Berman MA, Tanabe S, Heesen M, Luo Y. Astrocytes express functional chemokine receptors. J. Neuroimmunol. 2000;111:109–121
  9. Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F, Dubois-Dalcq M. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia. 2005;50:258–269
  10. Franklin RJM. Why does remyelination fail in multiple sclerosis?. Nat. Rev., Neurosci. 2002;3:705–714
  11. Fryer AD, Stein LH, Nie Z, Curtis DE, Evans CM, Hodgson ST, et al. Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J. Clin. Invest. 2006;116:228–236
  12. Höpfner M, Maaser K, Barthel B, von Lampe B, Hanski C, Riecken EO, et al. Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate. Int. J. Colorectal Dis. 2001;16:154–166
  13. Horuk R. Chemokines and HIV-1: the fusion of two major research fields. Immunol. Today. 1999;20:89–94
  14. Johnson Z, Schwarz M, Power CA, Wells TNC, Proudfoot AEI. Multi-faceted strategies to combat disease by interference with the chemokine system. Trends Immunol. 2005;26:268–274
  15. Kadi L, Selvaraju R, de Lys P, Proudfoot AEI, Wells TNC, Boschert U. Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J. Neuroimmunol. 2006;174:133–146
  16. Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J. Immunol. 2004;172:2853–2860
  17. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002;8:500–507
  18. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 1980;85:890–902
  19. Neves SR, Ram PT, Iyengar R. G protein pathways. Science. 2002;296:1636–1639
  20. Nguyen D, Stangel M. Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Dev. Brain Res. 2001;128:77–81
  21. Nguyen D, Höpfner M, Zobel F, Henke U, Scherübl H, Stangel M. Rat oligodendroglial cell lines express a functional receptor for the chemokine CCL3 (macrophage inflammatory protein-1alpha, MIP-1alpha). Neurosci. Lett. 2003;351:71–74
  22. Omari KM, John GR, Sealfon SC, Raine CS. CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain. 2005;128:1003–1025
  23. Omari KM, John G, Lango R, Raine CS. Role of CXCR2 and CXCL1 on glia in multiple sclerosis. Glia. 2006;53:24–31
  24. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. The chemokine growth-regulated oncogene-α promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci. 1998;15:10457–10463
  25. Stangel M, Hartung H-P. Remyelinating strategies for the treatment of multiple sclerosis. Prog. Neurobiol. 2002;68:361–376
  26. Stangel M, Compston A, Scolding NJ. Oligodendroglia are protected from antibody mediated complement injury by normal immunoglobulins (“IVIg”). J. Neuroimmunol. 2000;103:195–201
  27. Thelen M. Dancing to the tunes of chemokines. Nat. Immunol. 2001;2:129–134
  28. Tsai H-H, Frost E, To V, Robinson S, Ffrench-Constant C, Geertman R, et al. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell. 2002;110:373–383
  29. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121–127
  30. Zou Y-R, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 1998;393:595–599

PII: S0165-5728(06)00205-0

doi: 10.1016/j.jneuroim.2006.05.021

Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 17-23 , September 2006

Article Tools

* Image Usage & Resolution